TABLE 1.
Human cell lines used in this study
| Cell type | Cell line | Phenotype | Origin | XP-D causative mutation | Reference |
|---|---|---|---|---|---|
| Primary human fibroblasts | XP8BR | XP-D/CS | United Kingdom | G675R | 8 |
| XPCS2 | XP-D/CS | France | G602D | 36 | |
| XP1JI | XP-D/CS | Japan | G47R | 14a | |
| XPCS1PV | XP-D/CS | Spain | R666W | This paper | |
| XPCS118LV | XP-D/CS | Belgium | R666W | This paper | |
| XP1NE | XP-D/CS (?) | United Kingdom | G47R | 37 | |
| CS4BR | CS | United Kingdom | |||
| XP1BR | XP-D | United Kingdom | R683W | 37 | |
| 1BR3 | Normal | United Kingdom | |||
| Immortalized human fibroblasts | XP8BR-hTert | XP-D/CS | United Kingdom | G675R | 8 |
| 1604-hTert | Normal | United Kingdom | |||
| Primary mouse fibroblasts | Normal | ||||
| TTD | R722W | 11 | |||
| XP-D/CS | G602D | Andressoo et al., submitted | |||
| XP-D/CS | G602D (xpa del exons 3 and 4) | ||||
| XP-A |